Citadel Advisors
TSRX

Citadel Advisors’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Citadel Advisors’s Portfolio TSRX Stock Details TSRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-38,816
Closed -$315K – 3240
2013
Q2 		$315K Buy
+38,816
New +$315K ﹤0.01% 2091